Pharmosa Biopharm Inc. (TPEX:6875)

Market Cap	5.15B -28.2%
Revenue (ttm)	136.72M +170.6%
Net Income	-237.74M
EPS	-1.85
Shares Out	129.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	78,916
Average Volume	189,757
Open	40.65
Previous Close	39.90
Day's Range	39.55 - 40.65
52-Week Range	37.00 - 65.00
Beta	0.33
RSI	21.38
Earnings Date	Mar 6, 2026

About Pharmosa Biopharm

Pharmosa Biopharm Inc., a biotechnology company, focuses on developing drugs in Taiwan. It develops L606, an inhalation/device combination for the treatment of pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease; and L608, an inhalation/device combination for the treatment of pulmonary vascular disease. The company was formerly known as Pharmosa Limited and changed its name to Pharmosa Biopharm Inc. in October 2016. Pharmosa Biopharm Inc. was founded in 2000 and is headquartered in Taipei, Taiwan...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6875